Table 2.
Variable list | Overall survival N (%) |
PFS N (%) |
|
---|---|---|---|
Age | <median vs. | 81 (59.5%) | 66 (49%) |
≥median | 73 (54.4%) | 61 (45.5%) | |
Male | 95 (55.8%) | 77 (45%) | |
Female | 59 (59%) | 50 (50%) | |
B-cell | 138 (57.9%) | 114 (47.8%) | |
T-cell | 16 (50%) | 13 (41%) | |
Indolent | 28 (58.3%) | 25 (52%) | |
Aggressive | 104 (57.4%) | 85 (47%) | |
Stage | I/II | 42 (65.6%) | 32 (50%) |
III/IV | 112 (54.3%) | 95 (46.1%) | |
Number of regimens | |||
≤2 | 100 (63.2%) p=0.018 | 83 (52.5%) p=0.036 | |
>2 | 54 (48.2%) | 44 (39%) | |
Disease status | |||
CR | 112 (61.5%) p=0.018 | 94 (51.5%) p=0.037 | |
PR/ SD | 42 (47.7%) | 33 (37%) |